PB2146: A PHASE 2, OPEN-LABEL STUDY OF LONCASTUXIMAB TESIRINE IN COMBINATION WITH RITUXIMAB (LONCA-R) IN PREVIOUSLY UNTREATED UNFIT/FRAIL PATIENTS WITH DIFFUSE LARGE B-CELL LYMPHOMA (DLBCL) (LOTIS-9)
| Autor: | J. Westin, J. M. Burke, A. E. Chapman, T. Kilavuz, C. Xu, Y. Shmuely, J. Radford |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2022 |
| Předmět: | |
| Zdroj: | HemaSphere, Vol 6, Pp 2017-2018 (2022) |
| Druh dokumentu: | article |
| ISSN: | 2572-9241 |
| DOI: | 10.1097/01.HS9.0000851416.21855.57 |
| Databáze: | Directory of Open Access Journals |
| Externí odkaz: |
|
Plný text